← all works
The effects of lowering LDL cholesterol with simvastatin plus ezetimibe in patients with chronic kidney disease (Study of Heart and Renal Protection): a randomised placebo-controlled trial
Why is this work in the frame?
A frame that forgets how it found something cannot be audited. These are the routes that admitted this work.
Canadian affiliationAn author listed a Canadian institution. This is the only route the usual frame has.
Abstract
No abstract. This is not a gap in this database — OpenAlex has none either. 23.3% of the frame is in this state, and the screen finds HALF as much metaresearch here, so the absence is a measured bias rather than a missing field.
The record
- Venue
- The Lancet
- Topic
- Lipoproteins and Cardiovascular Health
- Field
- Medicine
- Canadian institutions
- University of British Columbia
- Funders
- National Medical Research CouncilMedical Research CouncilNational Health and Medical Research CouncilBritish Heart Foundation
- Keywords
- SimvastatinEzetimibeMedicineKidney diseasePlaceboInternal medicineCholesterolStatinLdl cholesterolCardiologyKidneyPathology
- Has abstract in OpenAlex
- no